Caries Inhibitory Effect of Nano Silver and Tri Calcium Phosphate Varnishes Among Visually Impaired Children
Prevention
1 other identifier
interventional
60
1 country
1
Brief Summary
Assessment of pH,streptococcus mutants count, lactobacillus count and immunoglobulin A among visually impaired children after nano silver varnish application it tri calcium phosphate phosphate varnish application
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2023
CompletedFirst Submitted
Initial submission to the registry
August 26, 2024
CompletedFirst Posted
Study publicly available on registry
August 29, 2024
CompletedAugust 29, 2024
August 1, 2024
6 months
August 26, 2024
August 28, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Salivary PH
Salivary power of hydrogen at baseline, one month, 3months and six months after intervention
6 months
Salivary streptococcus mutants count
Count of bacteria at baseline, one day, 3months and six months after intervention
6months
Lactobacillus count
Count of bacteria at baseline, one day, 3months and six months after intervention
6 months
Immunoglobulin A
Level of immunoglobulin A at saliva at baseline, one day, 3months and 6 months after intervention
6months
Study Arms (3)
nano silver varnish
EXPERIMENTALnew fluoride varnish
tri calcium phosphate varnish
EXPERIMENTALfluoride varnish contain calcium phosphate
health education
NO INTERVENTIONInterventions
Fluoride varnishes
Eligibility Criteria
You may qualify if:
- Visually impaired children
You may not qualify if:
- uncooperative children or children not willing to participate in the study.
- Children with systemic diseases
- Children with bronchial asthma.
- Children who were on antibiotic or medications that might affect oral flora or salivary flow taken within the previous 3 months
- History of fluoride treatment in the past 3-4 weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hadeer Mohammed Abd El wahablead
- Tanta Universitycollaborator
Study Sites (1)
Faculty of dentistry
Tanta, Tanta City, 31527, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hatem Amin, PhD
Faculty of dentistry . Tanta university
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- El Mahalla Elkobra
Study Record Dates
First Submitted
August 26, 2024
First Posted
August 29, 2024
Study Start
October 11, 2022
Primary Completion
April 11, 2023
Study Completion
April 13, 2023
Last Updated
August 29, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share